Multiple Myeloma Research Consortium

Organisation

Trials

  • NCT05560399

    Collaborator, Early phase 1, Active, not recruiting, 7 people, 29 Sept 2022

  • NCT04150965

    Phase 1/2, Terminated, 14 people, 5 Nov 2019

  • NCT03773107

    Collaborator, Phase 1/2, Completed, 12 people, 12 Dec 2018

  • NCT03732703

    Phase 1/2, Completed, 103 people, 7 Nov 2018

  • NCT03252600

    Collaborator, Phase 2, Status unknown, 53 people, 17 Aug 2017

  • NCT03091257

    Collaborator, Phase 1, Active, not recruiting, 30 people, 27 Mar 2017

  • NCT02952573

    Collaborator, Phase 2, Terminated, 20 people, 2 Nov 2016

  • NCT02903381

    Collaborator, Phase 2, Completed, 8 people, 16 Sept 2016

  • NCT02765854

    Collaborator, Phase 2, Completed, 70 people, 9 May 2016

  • NCT02718833

    Collaborator, Phase 2, Active, not recruiting, 52 people, 24 Mar 2016

  • NCT02279394

    Collaborator, Phase 2, Completed, 51 people, 31 Oct 2014

  • NCT02253316

    Collaborator, Phase 2, Active, not recruiting, 236 people, 1 Oct 2014

  • NCT01672736

    Collaborator, Phase 1/2, Terminated, 19 people, 27 Aug 2012

  • NCT01562405

    Collaborator, Phase 1, Active, not recruiting, 33 people, 23 Mar 2012

  • NCT01549431

    Collaborator, Phase 1, Completed, 32 people, 9 Mar 2012

  • NCT01497093

    Collaborator, Phase 1, Completed, 34 people, 22 Dec 2011

  • NCT01485835

    Collaborator, Phase 1, Completed, 8 people, 6 Dec 2011